InhaleRx Surges 77% After Securing Nearly AU$39 Million for Clinical Trials; Shares Surge 59%

InhaleRx獲得近3900萬澳元用於臨床試驗後，股價上漲77％；股價飆升59％。

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

登入免費觀看全文